Therefore, a potent and specific inhibitor of Kv1.2 would be helpful in restoring the normal neuronal excitability and alleviating the pathological effects associated with Kv1.2 GOF mutations in EE patients. The gene discussed is KCNA2; the disease is ethylmalonic encephalopathy.